- Home
- BXP vs NBIX Comparison
BXP vs NBIX Comparison
Compare BXP & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BXP
- NBIX
- Stock Information
- Founded
- BXP 1970
- NBIX 1992
- Country
- BXP United States
- NBIX United States
- Employees
- BXP N/A
- NBIX N/A
- Industry
- BXP Real Estate Investment Trusts
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BXP Real Estate
- NBIX Health Care
- Exchange
- BXP Nasdaq
- NBIX Nasdaq
- Market Cap
- BXP N/A
- NBIX 11.0B
- IPO Year
- BXP 1997
- NBIX 1996
- Fundamental
- Price
- BXP $67.80
- NBIX $108.31
- Analyst Decision
- BXP Buy
- NBIX Buy
- Analyst Count
- BXP 13
- NBIX 21
- Target Price
- BXP $80.85
- NBIX $166.75
- AVG Volume (30 Days)
- BXP 1.5M
- NBIX 1.2M
- Earning Date
- BXP 04-29-2025
- NBIX 04-30-2025
- Dividend Yield
- BXP 5.81%
- NBIX N/A
- EPS Growth
- BXP N/A
- NBIX 33.20
- EPS
- BXP 0.09
- NBIX 3.29
- Revenue
- BXP $3,380,319,000.00
- NBIX $2,355,300,000.00
- Revenue This Year
- BXP $1.59
- NBIX $15.48
- Revenue Next Year
- BXP $2.97
- NBIX $16.18
- P/E Ratio
- BXP $831.25
- NBIX $32.91
- Revenue Growth
- BXP 4.45
- NBIX 24.81
- 52 Week Low
- BXP $56.46
- NBIX $105.18
- 52 Week High
- BXP $90.11
- NBIX $157.98
- Technical
- Relative Strength Index (RSI)
- BXP 47.41
- NBIX 37.19
- Support Level
- BXP $67.82
- NBIX $113.05
- Resistance Level
- BXP $69.43
- NBIX $112.74
- Average True Range (ATR)
- BXP 1.68
- NBIX 2.65
- MACD
- BXP 0.09
- NBIX 0.35
- Stochastic Oscillator
- BXP 61.96
- NBIX 24.25
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.